After a brutal two-day selloff that saw Infosys and Wipro ADRs plunge as much as 14.5%, Friday’s session brought a much-needed breather. Bargain hunting kicked in at lower levels, sparking a sharp rebound as Infosys climbed 4% while Wipro gained 3%—helping both stocks close the week on a far stronger note. As much as Rs…
Nuvama on NYKAA: Buy| Target Rs 285 (vs Rs 235)| LTP Rs 245| Upside 16% Nuvama on Nykaa: Nuvama has maintained a Buy rating on Nykaa and raised the target price to Rs 285 from Rs 235, indicating a 16% upside from the current level of Rs 245. (Disclaimer: Recommendations, suggestions, views, and opinions given…
Zerodha founder and CEO Nithin Kamath reflected on the company’s unconventional growth journey, highlighting how customer referrals and word-of-mouth publicity, rather than advertising, have helped the discount broker acquire customers since its inception. “When we started Zerodha, we didn’t have the money to advertise, not that it would’ve worked,” Kamath wrote on X (formerly Twitter)….
Jefferies said its top stock picks among engineering and construction companies are Hindustan Aeronautics, Siemens, Larsen & Toubro and KEI Industries. The brokerage said the order flow of companies in these segments rose by 28% in FY25, led by HAL and Siemens. Agencies “Operating leverage was seen for most companies led by defence stocks, which…
Emkay Global has a ‘buy’ rating on Metropolis Healthcare and a target price of Rs 2,200, a potential upside of 12.2%. (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times) Source link